The merger is on track with a shareholder vote on September 4. The supplemental disclosures are unlikely to alter the outcome. Monitor the vote and any regulatory approvals; the stock should trade near the $150 offer price until closing.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 25 $145.25entry
- T+1 · 3mo ago +0.01%α −0.02% · $145.26
- T+5 · 3mo ago +0.16%α +0.70% · $145.48
- T+20 · 8w ago +0.86%α +0.61% · $146.50
- T+58 · todayOpen
- T+60 · tomorrow Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Arcosa filed a DEFA14A supplementing its definitive proxy statement for the pending merger with CRH Americas, Inc. The supplement adds disclosures from financial advisors' analyses and addresses stockholder litigation alleging inadequate disclosures. The merger consideration remains $150.00 per share, and the special meeting is scheduled for September 4, 2026.
Key Financial Metrics
Key Facts
- Special meeting to vote on merger with CRH Americas, Inc. set for September 4, 2026.
- Merger consideration: $150.00 per share.
- Two stockholder lawsuits filed in New York Supreme Court alleging inadequate proxy disclosures; company voluntarily supplements proxy statement.
- Supplemental disclosures include detailed financial analyses from Evercore and Goldman Sachs, including net debt of ~$1.026B and ~49.6M fully diluted shares.
- Analyst price targets as of June 18, 2026 ranged from $140 to $152 per share.
- No directors or executive officers have entered into new employment agreements with the company or parent in connection with the merger.
Financial Impact
Merger consideration of $150.00 per share; supplemental disclosures provide additional valuation context but do not change deal terms.
Risk Factors
- Shareholder vote could fail if sufficient opposition emerges.
- Regulatory approvals may be delayed or denied.
- Litigation could delay closing or result in additional costs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-034252 |
| Document: 0001140361-26-034252-index.html | 0001140361-26-034252 |
| Document: 0001140361-26-034252.txt | 0001140361-26-034252 |
Track record
16 reports on ACA
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +17.74% at T+60 after the Jun 5, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
- Nov 2, 202614d ago 15-12G Neutral 3/10 No price data
- Oct 23, 202624d ago 25-NSE Mixed 8/10 Entry $149.50 settles Jan 21
- Oct 23, 202624d ago 25-NSE Bullish 7/10 Entry $149.50 settles Jan 21
- Oct 23, 202624d ago 8-K / 25-NSE Mixed 8/10 Entry $149.50 settles Jan 21
- Aug 25, 202611w ago DEFA14A Neutral 3/10 Viewing Entry $145.25 settles Nov 18
- Aug 14, 202613w ago Institutional Cluster Mixed 5/10 Entry $145.01 due Nov 10
- Aug 5, 202614w ago DEFA14A Neutral 4/10 Entry $144.89 No price data
- Jun 22, 202621w ago DEFA14A Bullish 7/10 Entry $144.92 to $145.45 ▲ +0.37% −3.59% vs SPY
- Jun 22, 202621w ago DEFA14A Bullish 7/10 Entry $144.92 to $145.45 ▲ +0.37% −3.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers